Clinical Trial Update: Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a therapy to prevent weight gain in patients treated with olanzapine. The trial assessed safety and efficacy, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia, Schizoaffective Disorders | Phase 3 | Status: COMPLETED | Results posted: 2009-09-30